NEW YORK, March 21 - Inpharmatica said Wednesday that Genentech of South San Francisco, Calif., has acquired a three-year non-exclusive subscription to Inpharmatica's Biopendium proteomic analysis system. 

Under the terms of the multi-million dollar agreement, Inpharmatica of London, UK, will develop a customized version of Biopendium for Genentech by incorporating Genentech's proprietary genome sequence data into the platform. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.